Cathepsin K is a critical protease in synovial fibroblast-mediated collagen degradation

American Journal of Pathology

Volumn 159, Issue 6, 2001, Pages 2167-2177

  Hou, Wu Shiun ^a   Li, Zhenqiang ^a   Gordon, Ronald E ^a   Chan, Kyle ^c   Klein, Michael J ^a   Levy, Roger ^a   Keysser, Martin ^b   Keyszer, Gernot ^d   Brömme, Dieter ^a  

^a MOUNT SINAI SCHOOL OF MEDICINE   (United States)

^b Regionales Rheumazentrum Rostock   (United States)

^c CELGENE CORPORATION   (United States)

^d MARTIN LUTHER UNIVERSITY HALLE WITTENBERG   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

CATHEPSIN B; CATHEPSIN K; CATHEPSIN L; CATHEPSIN S; CD68 ANTIGEN; COLLAGEN FIBRIL; COLLAGEN TYPE 1; COLLAGEN TYPE 2; MATRIX METALLOPROTEINASE; PROTEINASE;

ADULT; ARTICLE; ARTICULAR CARTILAGE; BONE EROSION; CARTILAGE DEGENERATION; CLINICAL ARTICLE; COLLAGEN DEGRADATION; CONTROLLED STUDY; DISEASE SEVERITY; FEMALE; FIBROBLAST; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; JOINT DESTRUCTION; MALE; OSTEOCLAST; PHAGOCYTOSIS; PRIORITY JOURNAL; PROTEIN EXPRESSION; RHEUMATOID ARTHRITIS; SYNOVIOCYTE; SYNOVIUM;

EID: 0035185895     PISSN: 00029440     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0002-9440(10)63068-4     Document Type: Article

References (46)

1. Molecular biology of cartilage and bone destruction
2. Pathogenesis of bone erosions in rheumatoid arthritis
3. Inhibition of cartilage proteoglycan release by a specific inactivator of cathepsin B and an inhibitor of matrix metalloproteinases. Evidence for two converging pathways of chondrocyte-mediated proteoglycan degradation
4. Invasive fibroblast-like synoviocytes in rheumatoid arthritis. Passive responders or transformed aggressors?
5. Pathogenesis of joint damage in rheumatoid arthritis
6. Joint destruction in arthritis: Metalloproteinases in the spotlight
7. Lysosomal cysteine endopeptidases in the degradation of cartilage and bone
8. Cysteine proteinase inhibitors decrease articular cartilage and bone destruction in chronic inflammatory arthritis
9. Inhibition of cartilage and bone destruction in adjuvant arthritis in the rat by a matrix metalloproteinase inhibitor
10. Emerging roles for cysteine proteases in human biology
11. Human cathepsin O2, a matrix protein-degrading cysteine protease expressed in osteoclasts. Functional expression of human cathepsin O2 in Spodoptera frugiperda and characterization of the enzyme
12. Cathepsin K, but not cathepsins B, L, or S, is abundantly expressed in human osteoclasts
13. The collagenolytic activity of cathepsin K is unique among mammalian proteinases
14. Human cathepsin K cleaves native type I and II collagens at the Nterminal end of the triple helix
15. Pycnodysostosis, a lysosomal disease caused by cathepsin K deficiency
16. Cathepsin K: Characterization of novel mutations in the pro and mature polypeptide regions causing pycnodysostosis
17. Selective induction of the secretion of cathepsins B and L by cytokines in synovial fibroblast-like cells
18. The American Rheumatism Association 1987 revised criteria for the classification of rheumatoid arthritis
19. Reduced joint counts in controlled clinical trials in rheumatoid arthritis
20. Interrelationship of outcome measures and process variables in early rheumatoid arthritis. A comparison of radiologic damage, physical disability, joint counts, and acute phase reactants
21. Evaluation of the percentage of functional decrease of the joints using a motor function
22. Comparative evaluation of a German version of the Health Assessment Questionnaire and the Hannover Functional Capacity Questionnaire
23. Collagenolytic activity of cathepsin K is specifically modulated by cartilage-resident chondroitin sulfates
24. Quantitative analysis of synovial membrane inflammation: A comparison between automated and conventional microscopic measurements
25. Vinyl sulfones as mechanismbased cysteine protease inhibitors
26. Localization of rat cathepsin K in osteoclasts and resorption pits: Inhibition of bone resorption cathepsin K-activity by peptidyl vinyl sulfones
27. Expression of human cathepsin K in Pichia pastoris and preliminary crystallographic studies of an inhibitor complex
28. Impaired osteoclastic bone resorption leads to osteopetrosis in cathepsin K-deficient mice
29. Human cathepsin O2, a novel cysteine protease highly expressed in osteoclastomas and ovary. Molecular cloning, sequencing and tissue distribution
30. Expression of cathepsin K messenger RNA in giant cells and their precursors in human osteoarthritic synovial tissues
31. Regulation of elastinolytic cysteine proteinase activity in normal and cathepsin K-deficient human macrophages
32. Expression of cathepsin K in lung epithelial cells
33. Expression of cathepsin K in the human embryo and fetus
34. Expression of cathepsin K in chordoma
35. Cathepsin K in thyroid epithelial cells: Sequence, localization and possible function in extracellular proteolysis of thyroglobulin
36. Cysteine proteinase cathepsin K mRNA is expressed in synovium of patients with rheumatoid arthritis and is detected at sites of synovial bone destruction
37. Pannus and pannocytes. Alternative models of joint destruction in rheumatoid arthritis
38. Etiology and pathogenesis of rheumatoid arthritis
39. Angiogenesis and arthritis
40. Expression of vascular endothelial growth factor in synovial fibroblasts is induced by hypoxia and interleukin 1beta
41. Impaired invariant chain degradation and antigen presentation and diminished collagen-induced arthritis in cathespin S null mice
42. Phagocytosis of bone collagen by osteoclasts in two cases of pycnodysostosis
43. Intracellular collagen fibers at the pannus-cartilage junction in rheumatoid arthritis
44. Metabolic activation stimulates acid production in synovial fibroblasts
45. Autocatalytic activation of cathepsin K